SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Interim Management Statement

21 Oct 2014 07:00

RNS Number : 8018U
Devro PLC
21 October 2014
 



For immediate release 21 October 2014

 

 

Devro plc

(the "Group")

 

Interim Management Statement

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today issues the following Interim Management Statement for the period from 1 July 2014 to date.

Trading has continued in line with expectations. The business now has had two quarters of growing sales volumes year on year, most notably in China, Japan and Germany, with demand generally showing signs of improvement. Inventory is reducing as expected.

The major investment projects in China and the USA are both proceeding to plan. The replacement of our existing facility in South Carolina addresses the older plant's continued underperformance; an eighteen month programme of transition to the new manufacturing operations has now commenced. Net debt to fund the two projects is rising in line with our expectations. The first phase of the restructuring of our operations in Scotland has been completed on schedule in August and the second phase will conclude at the end of Q1 2015.

The outlook for the full year remains unchanged.

 

ENDS

 

 

For further information, please contact:

 

Devro plc

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

 

 

Tel No: 020 7182 4960

 

Buchanan

Charles Ryland / Sophie McNulty/

Clare Akhurst

 

 

 

Tel No: 020 7466 5000

 

Notes to Editors

 

FTSE listed Devro is one of the world's leading providers of collagen casings to the food industry supplying a wide range of products and technical support to manufacturers of sausages, salamis, hams and other cooked meats. The Group employs 2,200 staff across the world and produces its casings from five manufacturing sites based in Scotland, Australia, the Czech Republic and the USA. Devro reported sales of £242.7 million and profit before tax (before exceptional items) of £38.8 million for the year ended 31 December 2013. Devro is a constituent of the FTSE4Good Index Series which recognises that the company's performance meets globally recognised corporate responsibility standards.

 

Further information on Devro can be found on the company's website: www.devro.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMZGKGVGDZM
Date   Source Headline
28th Feb 202310:37 amGNWForm 8.3 - [Devro plc - 27 02 2023] - (CGWL)
28th Feb 20239:34 amRNSForm 8.3 - Devro Plc
27th Feb 20235:08 pmRNSForm 8.5 (EPT/RI)Devro plc- Amend
27th Feb 20233:30 pmGNWForm 8.3 - Devro plc
27th Feb 20233:20 pmRNSForm 8.3 -Devro plc
27th Feb 202311:42 amRNSForm 8.5 (EPT/RI)-Devro plc
27th Feb 202310:06 amRNSForm 8.3 - DEVRO PLC
27th Feb 20239:39 amRNSForm 8.3 - Devro Plc
27th Feb 20238:12 amRNSForm 8.3 - Devro plc
24th Feb 20233:20 pmRNSForm 8.3 - Devro plc
24th Feb 20231:47 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
24th Feb 20231:45 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
24th Feb 20231:30 pmBUSForm 8.3 - DEVRO PLC
24th Feb 20231:04 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
24th Feb 202311:21 amRNSForm 8.3 - DEVRO PLC
24th Feb 202311:06 amBUSForm 8.3 - Devro plc
24th Feb 202310:56 amRNSForm 8.3 - Devro Plc
24th Feb 202310:48 amRNSForm 8.5 (EPT/RI) - Devro plc
24th Feb 202310:03 amRNSForm 8.5 (EPT/RI) - Devro PLC
24th Feb 20239:33 amRNSForm 8.5 (EPT/RI)-Devro plc Amend
23rd Feb 20233:20 pmRNSForm 8.3 - Devro plc
23rd Feb 20232:47 pmRNSForm 8.3 - Devro plc
23rd Feb 20231:43 pmGNWForm 8.3 - [Devro plc - 22 02 2023] - (CGWL)
23rd Feb 20231:16 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
23rd Feb 202311:24 amRNSForm 8.3 - Devro Plc
23rd Feb 202311:09 amRNSForm 8.3 - DEVRO PLC
23rd Feb 202311:08 amRNSForm 8.5 (EPT/RI)-Devro plc
23rd Feb 20239:53 amRNSForm 8.5 (EPT/RI) - Devro PLC
23rd Feb 20239:23 amRNSForm 8.3 - Devro plc
23rd Feb 20237:25 amRNSForm 8.3 - DEVRO PLC Amendment
22nd Feb 20234:27 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
22nd Feb 20232:55 pmRNSForm 8.3 - Devro plc
22nd Feb 20231:30 pmBUSForm 8.3 - DEVRO PLC
22nd Feb 20231:24 pmRNSForm 8.3 - DEVRO PLC
22nd Feb 202310:41 amRNSForm 8.5 (EPT/NON-RI) - Devro plc
22nd Feb 202310:39 amRNSForm 8.5 (EPT/NON-RI) - Devro plc
22nd Feb 202310:35 amRNSForm 8.5 (EPT/RI) - Devro plc
22nd Feb 20238:14 amRNSForm 8.3 - Devro Plc
22nd Feb 20237:00 amRNSForm 8.3 - Devro plc
22nd Feb 20237:00 amRNSForm 8.5 (EPT/RI)-Devro plc Amend
22nd Feb 20237:00 amRNSForm 8.5 (EPT/RI)-Devro plc Amend
21st Feb 20236:29 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
21st Feb 202312:21 pmRNSForm 8.3 - DEVRO PLC
21st Feb 202311:43 amRNSForm 8.3 - Devro plc
21st Feb 202311:30 amRNSForm 8.5 (EPT/RI)-Devro plc
21st Feb 20239:07 amRNSForm 8.3 - Devro plc
21st Feb 20238:44 amRNSForm 8.3 - Devro Plc
20th Feb 20233:20 pmRNSForm 8.3 - Devro plc
20th Feb 20231:30 pmBUSForm 8.3 - DEVRO PLC
20th Feb 202312:40 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.